| %EE | Percent entrapment efficiency |
| ANOVA | One-way analysis of variance |
| BBD | Box–Behnken design |
| CH | Chitosan |
| CH-NPs | Chitosan NPs |
| CMA | Critical material attributes |
| CPP | Critical process parameters |
| CQA | Critical quality attributes |
| DOE | Design of experiments |
| E. | Entamoeba |
| FFD | Fractional factorial design |
| GI | Gastrointestinal |
| ICH | International Council for Harmonization |
| Met | Metronidazole |
| MetNp | Met containing NPs |
| MetNp Cap | Eudragit coated capsule containing MetNp |
| MTP1 | Metal tolerance proteins-1 |
| NPs | Nanoparticles |
| PNP | Purine nucleoside phosphorylase |
| PS | Particle size |
| QbD | Quality by design |
| QTPP | Quality target product profile |
| R2adj | Adjusted coefficient of determination |
| RDC | Residual drug content |
| RSM | Response surface methodology |
| Sc | Surface area of the uncoated capsule |
| SCF | Simulated colonic fluid |
| SGF | Simulated GI fluid |
| SGIF | Simulated gastric and intestinal fluid |
| SIF | Simulated intestinal fluid |
| SOD | Superoxide dismutase |
| TPP | Tripolyphosphate |
| Trx | Thioredoxin |
| TrxR | Thioredoxin reductase |
| ρo | Bulk density |
| ρt | Tapped density |
| Wc | Weight of uncoated capsule |
| Wec | Weight of enteric-coated capsule |